Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  enzastaurin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 44 for your search:
Start Over
Enzastaurin Versus Lomustine in Glioblastoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9817, H6Q-MC-JCBF, NCT00295815
PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9823, H6Q-MC-JCBJ, PRELUDE, NCT00332202
Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9815, H6Q-MC-S008, NCT00402116
A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11183, H6Q-MC-S030, NCT00452413
Phase II Study of LY317615 in Patients With Recurrent High-Grade Gliomas
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-03-C-0018, NCT00052663
Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8360, H6Q-MC-JCAO, NCT00088205
Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8670, H6Q-MC-JCAQ, NCT00105092
Enzastaurin for Patients With Metastatic Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9098, H6Q-MC-JCAR, NCT00192114
Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Patients With Advanced or Metastatic Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10463, H6Q-US-S002, NCT00267020
First Line Chemotherapy Treatment of Advanced NSCLC
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10651, H6Q-US-S004, NCT00308750
An Open Label Study of Oral Enzastaurin in Patients With Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10287, H6Q-MC-S001, NCT00309140
Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10517, H6Q-MC-S015, NCT00386087
Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000517318, GOG-0170J, LILLY-H6Q-MC-S025, NCT00407758
Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10708, H6Q-MC-S019, NCT00391118
A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers
Phase: Phase II
Type: Prevention
Status: Completed
Age: 45 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10723, H6Q-MC-S009, MCC-14787, MCC-104545, LILLY-H6Q-MC-S009A, U01-CA-101222, NCT00387816, NCT00414960
Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10710, H6Q-MC-S020, NCT00415363
Phase 2 Trial of Enzastaurin in Prostate Cancer in Patients Who Have Had Hormonal and Chemotherapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10737, H6Q-MC-S024, NCT00428714
Chemotherapy for Patients With Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9819, H6Q-MC-S013, NCT00436280
A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10538, H6Q-MC-S018, NCT00437268
An Study of Patients With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Patients Who Take R-CHOP Only
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9824, H6Q-MC-S028, NCT00451178
Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10736, H6Q-MC-S023, NCT00451555
A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11311, H6Q-MC-S032, NCT00466440
A Study of Enzastaurin in Patients With Follicular Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8671, H6Q-MC-S011, NCT00475644
A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 4849, H6Q-MC-JCAI, UCLA-0210010, LILLY-H6Q-MC-JCA, CWRU-080213J, LILY-1402, UNMC-18502, NCT00042666
Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Patients With Newly Diagnosed Glioblastoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11491, H6Q-MC-S039, NCT00509821
Start Over